Atlas Trials

PK of Melphalan During Treatment With Melflufen and Dexamethasone in Patients With RRMM and Impaired Renal Function

Clinical trial NCT03639610 · TERMINATED

Trial details

NCT number
NCT03639610
Sponsor
Oncopeptides AB
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Renal ImpairmentMultiple Myeloma
Start date
2018-08-28
Primary completion
2021-12-22
Enrollment
35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.